Violation Tracker Summary for Primary Offense Type

Offense Type: 
False Claims Act and related
Penalty Total since 2000: 
$48,731,818,230
Number of Penalty Records: 
3,086
Note: 
The totals here are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.

Top 10 Parent CompaniesTotal Penalty $Number of Records
Tenet Healthcare$1,639,152,25417
HCA Healthcare$1,536,737,05813
Takeda Pharmaceutical$1,246,349,91010
Wells Fargo$1,204,046,7862
DaVita HealthCare Partners$1,133,700,0005
Pfizer$1,109,688,43519
Viatris$1,011,761,15731
Boeing$979,303,63314
Bechtel$911,475,0004
Merck$818,033,33315


Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
Company Parent Parent Major Industrysort icon Year Agency Penalty Amount
Sanofi-Pasteur Sanofi pharmaceuticals 2017 DOJ_CIVIL $19,868,194
Novo Nordisk Inc. Novo Holdings A/S pharmaceuticals 2017 DOJ_CIVIL $58,650,000
Mylan Inc. Viatris pharmaceuticals 2017 DOJ_CIVIL $465,000,000
SmithKline Beecham GlaxoSmithKline pharmaceuticals 2003 DOJ_CIVIL $47,000,000
Abbott Laboratories and CG Nutritionals Abbott Laboratories pharmaceuticals 2003 DOJ_CIVIL $600,000,000
Galena Biopharma Inc. SELLAS Life Sciences Group pharmaceuticals 2017 USAO $7,550,000
Celgene Corp. Bristol-Myers Squibb pharmaceuticals 2017 USAO $280,000,000
Mallinckrodt LLC Mallinckrodt pharmaceuticals 2013 USAO $3,500,000
Novo Nordisk Inc. Novo Holdings A/S pharmaceuticals 2011 USAO $1,725,000
Forest Pharmaceuticals Inc. AbbVie pharmaceuticals 2010 USAO $149,000,000
Depuy Orthopaedics Inc. Johnson & Johnson pharmaceuticals 2007 USAO $84,700,000
Purdue Frederick Company Inc. Purdue Pharma pharmaceuticals 2007 USAO $461,900,000
United Therapeutics Corporation United Therapeutics pharmaceuticals 2017 DOJ_CIVIL $210,000,000
Alere Inc. Abbott Laboratories pharmaceuticals 2018 DOJ_CIVIL $33,200,000
Allergan Inc. AbbVie pharmaceuticals 2018 USAO $3,500,000
Pfizer, Inc. Pfizer pharmaceuticals 2018 DOJ_CIVIL $23,850,000
Actelion Pharmaceuticals US, Inc. Johnson & Johnson pharmaceuticals 2018 DOJ_CIVIL $360,000,000
Insys Therapeutics Insys Therapeutics pharmaceuticals 2019 DOJ_CIVIL $225,000,000
Astellas Pharma US Inc. Astellas Pharma pharmaceuticals 2019 DOJ_CIVIL $100,000,000
Amgen Inc. Amgen pharmaceuticals 2019 DOJ_CIVIL $24,750,000
Jazz Pharmaceuticals plc Jazz Pharmaceuticals pharmaceuticals 2019 DOJ_CIVIL $57,000,000
Lundbeck LLC Lundbeck pharmaceuticals 2019 DOJ_CIVIL $52,600,000
Alexion Pharmaceuticals Inc. AstraZeneca pharmaceuticals 2019 DOJ_CIVIL $13,000,000
Abbott Laboratories Abbott Laboratories pharmaceuticals 2003 MULTI-AG (*) $32,500,000
Abbott Laboratories AbbVie pharmaceuticals 2009 AL-AG $14,833,333
Abbott Laboratories AbbVie pharmaceuticals 2013 LA-AG $6,200,000
Abbott Laboratories AbbVie pharmaceuticals 2008 PA-AG $6,950,000
Abbott Laboratories Inc. AbbVie pharmaceuticals 2009 OH-AG $1,340,000
Abbott Laboratories Inc. AbbVie pharmaceuticals 2008 TX-AG $28,000,000
Abbott Laboratories, Inc. AbbVie pharmaceuticals 2009 IA-AG $357,000
Abbott Laboratories, Inc. AbbVie pharmaceuticals 2013 ID-AG $1,000,000
Actavis AbbVie pharmaceuticals 2012 LA-AG $4,000,000
Actavis Elizabeth LLC Teva Pharmaceutical Industries pharmaceuticals 2010 MA-AG $3,600,000
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC Teva Pharmaceutical Industries pharmaceuticals 2011 TX-AG $29,230,000
Aegerion Pharmaceuticals Inc. Amryt Pharma pharmaceuticals 2017 MULTI-AG (*) $2,700,000
Alere Inc. Abbott Laboratories pharmaceuticals 2018 MULTI-AG (*) $4,860,779
Alpharma Inc. Pfizer pharmaceuticals 2010 MULTI-AG (*) $8,900,000
Alpharma USPD, Inc. Pfizer pharmaceuticals 2010 ID-AG $600,000
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. Pfizer pharmaceuticals 2011 KY-AG $10,200,000
Alpharma USPD, Inc., Pfizer pharmaceuticals 2011 MS-AG $2,010,667
Amgen and Immunex Amgen pharmaceuticals 2008 AL-AG $3,500,000
Amgen Inc. Amgen pharmaceuticals 2009 IL-AG $7,200,000
Amgen Inc. Amgen pharmaceuticals 2008 WI-AG $2,000,000
Amgen, Inc. Amgen pharmaceuticals 2013 MULTI-AG $11,000,000
Amgen, Inc. Amgen pharmaceuticals 2009 IA-AG $357,000
Amgen, Inc. Amgen pharmaceuticals 2009 KY-AG $2,400,000
Apotex Apotex Corp. pharmaceuticals 2013 LA-AG $4,000,000
Astellas Astellas Pharma pharmaceuticals 2013 LA-AG $1,130,000
Astellas Pharma US Inc. Astellas Pharma pharmaceuticals 2014 MULTI-AG (*) $3,100,000
AstraZeneca AstraZeneca pharmaceuticals 2004 FL-AG $807,826
AstraZeneca AstraZeneca pharmaceuticals 2009 KY-AG $14,700,000
AstraZeneca AstraZeneca pharmaceuticals 2018 TX-AG $110,000,000
AstraZeneca LP AstraZeneca pharmaceuticals 2015 MULTI-AG (*) $46,500,000
AstraZeneca Pharmaceuticals LP AstraZeneca pharmaceuticals 2003 MULTI-AG (*) $24,900,000
AstraZeneca Pharmaceuticals LP AstraZeneca pharmaceuticals 2009 MULTI-AG (*) $2,600,000
AstraZeneca Pharmaceuticals LP and AstraZeneca LP AstraZeneca pharmaceuticals 2011 ID-AG $2,500,000
AstraZeneca Pharmaceuticals, LP AstraZeneca pharmaceuticals 2010 HI-AG $3,333,333
Aventis Sanofi pharmaceuticals 2013 LA-AG $7,000,000
Aventis Pharmaceutical Inc. Sanofi pharmaceuticals 2009 MULTI-AG (*) $40,000,000
Aventis Pharmaceutical L.P. Sanofi pharmaceuticals 2009 AL-AG $14,833,333
Aventis Pharmaceuticals Inc. Sanofi pharmaceuticals 2007 MULTI-AG (*) $10,645,600
Aventis Pharmaceuticals Inc. Sanofi pharmaceuticals 2010 NJ-AG $1,300,000
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC Sanofi pharmaceuticals 2012 KY-AG $2,290,000
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. Teva Pharmaceutical Industries pharmaceuticals 2007 MA-AG $2,000,000
Ben Venue Laboratories, Inc. Boehringer Ingelheim pharmaceuticals 2009 IA-AG $357,000
Biovail Bausch Health pharmaceuticals 2013 LA-AG $200,000
Boehringer Ingelheim Boehringer Ingelheim pharmaceuticals 2012 LA-AG $3,250,000
Boehringer Ingelheim Corp. Boehringer Ingelheim pharmaceuticals 2005 TX-AG $10,000,000
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim pharmaceuticals 2010 WI-AG $7,750,000
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. Boehringer Ingelheim pharmaceuticals 2009 KY-AG $4,500,000
Boehringer Ingelheim Roxane, Inc. Boehringer Ingelheim pharmaceuticals 2008 MA-AG $1,800,000
Boehringer Ingelheim Roxane, Inc. et al. Boehringer Ingelheim pharmaceuticals 2009 IA-AG $357,000
Boehringer Ingleheim Boehringer Ingelheim pharmaceuticals 2011 KS-AG $1,400,000
Bristol-Myers Squibb Bristol-Myers Squibb pharmaceuticals 2008 MULTI-AG (*) $187,000,000
Bristol-Myers Squibb Bristol-Myers Squibb pharmaceuticals 2008 AL-AG $11,000,000
Bristol-Myers Squibb Bristol-Myers Squibb pharmaceuticals 2010 PA-AG $27,600,000
Bristol-Myers Squibb Company and Apothecon, Inc. Bristol-Myers Squibb pharmaceuticals 2008 ID-AG $1,738,719
Cephalon, Inc. Teva Pharmaceutical Industries pharmaceuticals 2015 MULTI-AG (*) $7,500,000
Daiichi Sankyo, Inc. Daiichi Sankyo pharmaceuticals 2015 MULTI-AG $39,000,000
Dava Pharmaceuticals, Inc. Endo International pharmaceuticals 2012 MULTI-AG (*) $11,000,000
Dey Viatris pharmaceuticals 2012 LA-AG $3,000,000
Dey Inc. Viatris pharmaceuticals 2005 CT-AG $2,500,000
Dey Inc. Viatris pharmaceuticals 2006 MO-AG $2,932,000
Dey Inc. Viatris pharmaceuticals 2006 OH-AG $4,000,000
Dey Inc. Viatris pharmaceuticals 2004 WV-AG $850,000
Dey L.P. Viatris pharmaceuticals 2008 AL-AG $4,750,000
Dey Labs Viatris pharmaceuticals 2009 MS-AG $3,900,000
Dey LP Viatris pharmaceuticals 2007 MT-AG $198,000
Dey Pharmaceuticals Viatris pharmaceuticals 2011 PA-AG $2,000,000
Dey, Inc. Viatris pharmaceuticals 2007 HI-AG $1,150,000
Dey, Inc. Viatris pharmaceuticals 2009 IA-AG $1,800,000
Dey, Inc. Viatris pharmaceuticals 2006 ID-AG $1,072,700
Dey, Inc. Viatris pharmaceuticals 2010 KY-AG $3,500,000
Dey, Inc. Viatris pharmaceuticals 2007 MA-AG $2,900,000
Dey, Inc. Viatris pharmaceuticals 2007 NV-AG $670,000
Dey, Inc. Viatris pharmaceuticals 2003 TX-AG $9,000,000
Dey, Inc. Viatris pharmaceuticals 2010 WI-AG $2,000,000
Eisai Eisai pharmaceuticals 2013 LA-AG $1,000,000
Eli Lilly Eli Lilly pharmaceuticals 2013 LA-AG $1,650,000
EMD Serono, Inc. Merck KGaA (EMD) pharmaceuticals 2011 MULTI-AG (*) $44,300,000
Endo Health Solutions Endo International pharmaceuticals 2015 MULTI-AG (*) $39,000,000
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
(*): Some penalties are partial or complete duplicates of other penalty records, either because a DOJ settlement duplicates an agency record or because EPA listed the full penalty for a company for each of the company's relevant facilities. Penalty amounts marked with an asterisk have been identified by Good Jobs First as duplicating other penalty amounts.